Charles Zhou

Stock Analyst at UBS

(0.3)
# 2510
Out of 5,329 analysts
13
Total ratings
50.00%
Success rate
-7.39%
Average return
8 Stocks
Name Action PT Current % Upside Ratings Updated
FUTU Futu Hldgs
Maintains: Strong Buy
130 136
93.71 45.13% 3 Mar 17, 2025
ZYME Zymeworks
Reiterates: Buy
16
12.92 23.84% 1 Mar 8, 2023
COGT Cogent Biosciences
Initiates Coverage On: Buy
15
5.64 165.96% 1 Jun 28, 2022
MGNX Macrogenics
Downgrades: Neutral
n/a
n/a n/a 1 May 5, 2022
PMVP PMV Pharma
Initiates Coverage On: Buy
56
1 5500% 1 Aug 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
46
1.43 3116.78% 1 Jun 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 3 Aug 25, 2017